The experimental treatment method allows small therapeutic agents to safely cross the blood-brain barrier in laboratory rats by turning off P-glycoprotein, one of the main gatekeepers preventing medicinal drugs from reaching their intended targets in the brain.
Fear responses can only be erased when people learn something new while retrieving the fear memory according to a new study.
Researchers identify a molecular pathway which accelerates the time taken for antidepressants to work in mouse models.
According to researchers, fMRI brain scans may be used to predict a patient's responsiveness to antipsychotic medications.
A new study could help identify those most vulnerable to nicotine and help find new ways to prevent or treat addiction.
Researchers explain how a molecular amplification system helps a new class of antidepressants alter brain signaling in specific neurons and how this produces the antidepressant effect.
According to a new study, lithium appears to be safe and effective in treating bipolar disorder in children, at least in the short term.
A new study reports people with Alzheimer's disease are more likely to use antipsychotic medications, and for longer periods of time, than the general public.
Study reveals why some people with bipolar disorder respond to lithium while others don't.
Researchers report people from OCD can benefit significantly from adding exposure and response prevention therapy when common drug treatments fail.